Therapy Analysis & Statistics, June 2014 (p30)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

871-900 of about 2 200 reports

Purchase Reports From Reputable Market Research Publishers

 Erectile Dysfunction- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Erectile Dysfunction- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Erectile Dysfunction- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Therapy
  • Countries : United States, World
 Hypercholesterolemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Hypercholesterolemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Hypercholesterolemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Therapy
  • Countries : United States, World
 Eye Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Eye Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Eye Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Therapy
  • Countries : United States, World
 Nausea - Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Nausea - Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Nausea - Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Respiratory Tract Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Respiratory Tract Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Respiratory Tract Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Thromboembolism- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Thromboembolism- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Thromboembolism- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Therapy
  • Countries : United States, World
Companion Diagnostics in Personalized Medicine and Cancer Therapy

Companion Diagnostics in Personalized Medicine and Cancer Therapy

  • $ 3 400
  • Industry report
  • June 2014
  • by TriMark Publications

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic ...

  • Industries : Therapy
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany The Glioblastoma Multiforme (GBM) treatment market is forecast to grow rapidly from $301 million in 2013 to $623 ...

  • Industries : Therapy
  • Countries : World
Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries

Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries

  • $ 4 995
  • Industry report
  • June 2014
  • by GBI Research

Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries Summary GBI Research, the leading business intelligence ...

  • Industries : Therapy
  • Countries : World
Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

  • $ 4 995
  • Industry report
  • June 2014
  • by GBI Research

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs Summary GBI Research, the leading business intelligence ...

  • Industries : Therapy
  • Countries : World
Hasselt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Hasselt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Hasselt University (HU) is an educational service provider. The university provides courses in various disciplines. It offers exchange programs and master programs. HU's exchange programs include ...

  • Industries : Therapy
CytomX Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CytomX Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary CytomX Therapeutics, Inc. (CytomX) is a biotechnology company. The company offers Probody platform which is a differentiated approach of discovering and developing empowered antibodies. It also ...

  • Industries : Therapy
  • Countries : United States
Global Choroidal Neovascularization (CNV) Market 2014-2018.pdf

Global Choroidal Neovascularization (CNV) Market 2014-2018.pdf

  • $ 2 500
  • Industry report
  • May 2014
  • by Infiniti Research Limited

About CNV CNV is defined as a process in which new blood vessels grow in the choroid through the bruch membrane, which is the innermost layer of the choroid, and attack the sub-retinal space. Even though ...

  • Industries : Therapy
  • Countries : World
Pain Therapeutics, Inc. - Product Pipeline Review - 2014

Pain Therapeutics, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

Pain Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Pain Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Pain Therapeutics, Inc.'s ...

  • Industries : Therapy
  • Countries : World
Wellstat Therapeutics Corporation - Product Pipeline Review - 2014

Wellstat Therapeutics Corporation - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

Wellstat Therapeutics Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Wellstat Therapeutics Corporation - Product Pipeline Review - 2014', provides an overview of the Wellstat ...

  • Industries : Therapy
  • Countries : World
Biological Therapy in United States: Northwest Biotherapeutics, Inc. – Product Pipeline Review – H2 2011

Biological Therapy in United States: Northwest Biotherapeutics, Inc. – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

- Product Pipeline Review - H2 2011” provides a detailed overview on the Northwest Biotherapeutics, Inc.’s research and development focus. The report includes data on current developmental pipeline, ...

  • Industries : Therapy
  • Countries : World
Pharmaceutical in United States: ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – H2 2011

Pharmaceutical in United States: ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

- Product Pipeline Review - H2 2011” provides a detailed overview on the ImmunoCellular Therapeutics, Ltd.’s research and development focus. The report includes information on current developmental ...

  • Industries : Therapy
  • Countries : World
Chemotherapy Induced Myelosuppression - Pipeline Review, H1 2014

Chemotherapy Induced Myelosuppression - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

Chemotherapy Induced Myelosuppression - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Chemotherapy Induced Myelosuppression - Pipeline Review, H1 2014', provides an overview of the Chemotherapy ...

  • Industries : Therapy
  • Countries : World
Drug and Medication Industry: United Therapeutics Corporation – Product Pipeline Review – H2 2011

Drug and Medication Industry: United Therapeutics Corporation – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...

  • Industries : Therapy
  • Countries : World
Fate Therapeutics, Inc. - Product Pipeline Review - 2014

Fate Therapeutics, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

Fate Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Fate Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Fate Therapeutics, Inc.'s ...

  • Industries : Therapy
  • Countries : World
Pathology Industry: Nektar Therapeutics – Product Pipeline Review – H2 2011

Pathology Industry: Nektar Therapeutics – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...

  • Industries : Therapy
  • Countries : World
BIND Therapeutics, Inc. - Product Pipeline Review - 2014

BIND Therapeutics, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

BIND Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Bind Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Bind Therapeutics, Inc.'s ...

  • Industries : Therapy
  • Countries : World
Protalix BioTherapeutics, Inc. - Product Pipeline Review - 2014

Protalix BioTherapeutics, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

Protalix BioTherapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Protalix BioTherapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Protalix ...

  • Industries : Therapy
  • Countries : World
Sarepta Therapeutics, Inc. - Product Pipeline Review - 2014

Sarepta Therapeutics, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

Sarepta Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Sarepta Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Sarepta Therapeutics, ...

  • Industries : Therapy
  • Countries : World
e-Therapeutics plc - Product Pipeline Review - 2014

e-Therapeutics plc - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

e-Therapeutics plc - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘e-Therapeutics plc - Product Pipeline Review - 2014', provides an overview of the e-Therapeutics plc's pharmaceutical ...

  • Industries : Therapy
  • Countries : World
Therapy in Brazil: Biotie Therapies Corp. – Product Pipeline Review – H2 2011

Therapy in Brazil: Biotie Therapies Corp. – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using ...

  • Industries : Therapy
  • Countries : World
Epistem Holdings Plc (EHP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Epistem Holdings Plc (EHP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Epistem Holdings Plc (Epistem) is a biopharmaceutical and biotechnology company providing contract research facilities and services to other pharmaceutical companies. It also undertakes the development ...

  • Industries : Therapy
Vectura Group plc (VEC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vectura Group plc (VEC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Vectura Group plc (Vectura) is a product development company, which develops inhaled pharmaceuticals using a range of proprietary lung delivery technologies, including device and formulation capabilities. ...

  • Industries : Therapy
  • Countries : China
Revance Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Revance Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Revance Therapeutics, Inc. (Revance) is a bio-pharmaceutical company. The company develops, manufactures and commercializes novel botulinum toxin products for multiple aesthetic and therapeutic ...

  • Industries : Therapy
  • Countries : United States
Dyax Corp. (DYAX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Dyax Corp. (DYAX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Dyax Corp. (Dyax) is a fully integrated biopharmaceutical company. It develops and markets of novel biotherapeutics for unmet medical needs in the fields of inflammation and oncology. The company's ...

  • Industries : Therapy
  • Countries : United States
About 300 reports

Download Unlimited Documents from Trusted Public Sources

Therapy Industry - Company Report, 2015

  • January 2015
    2 pages
  • Therapy  

    Credit And Loan  

  • United States  

View report >

Therapy Markets In The Us

September 2014

52 Companies

Read our Company Profiles

Pfizer Inc.

United States

GlaxoSmithKline P.L.C.

United States

Bristol-Myers Squibb Co.

United States

GlaxoSmithKline PLC

United Kingdom

Baxter Healthcare Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.